Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL: PF-04360365 0.1 mg/kg
BIOLOGICAL: PF-04360365 0.5 mg/kg
BIOLOGICAL: PF-04360365 1 mg/kg
DRUG: Placebo
BIOLOGICAL: PF-04360365 3 mg/kg
BIOLOGICAL: PF-04360365 8.5 mg/kg

Sponsor

Pfizer